Patent details

EP1128829 Title: RILUZOLE AND ALPHA-TOCOPHEROL COMBINATION

Basic Information

Publication number:
EP1128829
PCT Application Number:
PCT/FR/1999/002753
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP999721012
PCT Publication Number:
WO/2000/028992
First applicant's nationality:
Translation Language:
EPO Publication Language:
French
English Title of Invention:
RILUZOLE AND ALPHA-TOCOPHEROL COMBINATION
French Title of Invention:
ASSOCIATION DE RILUZOLE ET D'ALPHA-TOCOPHEROL
German Title of Invention:
ZUSAMMENSETZUNG VON RILUZOL UND ALPHA-TOCOPHEROL
SPC Number:

Dates

Filing date:
09/11/1999
Grant date:
11/05/2005
EP Publication Date:
11/05/2005
PCT Publication Date:
25/05/2000
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
05/09/2001
EP B1 Publication Date:
11/05/2005
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
09/11/2013
Expiration date:
09/11/2019
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/11/1999
 
 

Name:
Aventis Pharma S.A.
Address:
20, avenue Raymond Aron, 92160 Antony, France (FR)

Inventor

Name:
DIB Michel
Address:
France (FR)

Priority

Priority Number:
9814250
Priority Date:
13/11/1998
Priority Country:
France (FR)

Classification

Main IPC Class:
A61K 31/425;
Filing date Document type Number of pages